IFNG and melanoma: While this suggests that tumor IFN-γ signaling may not impart TILs, a caveat is that IFNγR1KD melanoma still has residual IFN-γ signaling and is not an ideal model to assess how the loss of IFN-γ signaling in tumor cells modulates TILs.